Literature DB >> 8039915

Mice infected with Trypanosoma cruzi produce antibodies against the enzymatic domain of trans-sialidase that inhibit its activity.

M S Leguizamón1, O E Campetella, S M González Cappa, A C Frasch.   

Abstract

trans-Sialidase (TS) is an enzymatic activity described only for trypanosomes that is involved in the invasion of host cells by Trypanosoma cruzi. The enzyme that is shed by the parasite is made of two domains, the C-terminal region containing immunodominant amino acid repeats that define the SAPA antigen and the N-terminal domain that contains the putative region for enzymatic activity. The SAPA antigen induces a strong humoral response detected shortly after infection, both in humans and in mice. This response is directed to the immunodominant domain but is irrelevant in terms of neutralization of TS activity. We now show that TS activity can be detected in sera from acutely infected mice. However, mice infected with a T. cruzi strain whose growth can be controlled by the host did not have detectable levels of TS activity in sera. In fact, sera from these mice were able to abolish TS activity. This inhibition was due to the presence of specific antibodies directed against the enzymatic domain of the protein since they also abolish the activity of a recombinant molecule lacking the immunodominant amino acid repeats. The neutralizing antibodies were present from day 30 after the infection, while antibodies to the immunodominant repeats were detected by day 8 postinoculation, suggesting that the in vivo role of these repeats is to defect the humoral response to the repeat domain until the infection is established.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039915      PMCID: PMC302976          DOI: 10.1128/iai.62.8.3441-3446.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  The complete sequence of a shed acute-phase antigen of Trypanosoma cruzi.

Authors:  G D Pollevick; J L Affranchino; A C Frasch; D O Sánchez
Journal:  Mol Biochem Parasitol       Date:  1991-08       Impact factor: 1.759

2.  Induction of macrophage activation and opsonizing antibodies by Trypanosoma cruzi subpopulations.

Authors:  A M Celentano; S M González Cappa
Journal:  Parasite Immunol       Date:  1992-03       Impact factor: 2.280

3.  Direct sialic acid transfer from a protein donor to glycolipids of trypomastigote forms of Trypanosoma cruzi.

Authors:  B Zingales; C Carniol; R M de Lederkremer; W Colli
Journal:  Mol Biochem Parasitol       Date:  1987-11       Impact factor: 1.759

4.  The Trypanosoma cruzi neuraminidase contains sequences similar to bacterial neuraminidases, YWTD repeats of the low density lipoprotein receptor, and type III modules of fibronectin.

Authors:  M E Pereira; J S Mejia; E Ortega-Barria; D Matzilevich; R P Prioli
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

5.  A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells.

Authors:  S Schenkman; M S Jiang; G W Hart; V Nussenzweig
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

6.  Bloodstream Trypanosoma cruzi parasites from mice simultaneously express antigens that are markers of acute and chronic human Chagas disease.

Authors:  M S Leguizamon; O E Campetella; M B Reyes; C F Ibañez; M A Basombrio; J Rincon; A Orn; A C Frasch
Journal:  Parasitology       Date:  1991-06       Impact factor: 3.234

7.  Incorporation of sialic acid into Trypanosoma cruzi macromolecules. A proposal for a new metabolic route.

Authors:  J O Previato; A F Andrade; M C Pessolani; L Mendonça-Previato
Journal:  Mol Biochem Parasitol       Date:  1985-06       Impact factor: 1.759

8.  Mapping of a B-cell epitope present in the neuraminidase of Trypanosoma cruzi.

Authors:  R P Prioli; E Ortega-Barria; J S Mejia; M E Pereira
Journal:  Mol Biochem Parasitol       Date:  1992-05       Impact factor: 1.759

9.  Mediation of Trypanosoma cruzi invasion by sialic acid on the host cell and trans-sialidase on the trypanosome.

Authors:  M Ming; M Chuenkova; E Ortega-Barria; M E Pereira
Journal:  Mol Biochem Parasitol       Date:  1993-06       Impact factor: 1.759

10.  The effect of fetuin and other sialoglycoproteins on the in vitro penetration of Trypanosoma cruzi trypomastigotes into fibroblastic cells.

Authors:  M M Piras; D Henríquez; R Piras
Journal:  Mol Biochem Parasitol       Date:  1987-01-15       Impact factor: 1.759

View more
  19 in total

1.  trans-sialidase inhibition assay, a highly sensitive and specific diagnostic test for Chagas' disease.

Authors:  A S Buchovsky; O Campetella; G Russomando; L Franco; R Oddone; N Candia; A Luquetti; S M Gonzalez Cappa; M S Leguizamon
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants.

Authors:  T A Pitcovsky; J Mucci; P Alvarez; M S Leguizamón; O Burrone; P M Alzari; O Campetella
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Continuous nonradioactive method for screening trypanosomal trans-sialidase activity and its inhibitors.

Authors:  Paula A Sartor; Rosalía Agusti; Maria S Leguizamón; Oscar Campetella; Rosa M de Lederkremer
Journal:  Glycobiology       Date:  2010-04-07       Impact factor: 4.313

4.  Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation.

Authors:  Romina P Muiá; Hai Yu; Jennifer A Prescher; Ulf Hellman; Xi Chen; Carolyn R Bertozzi; Oscar Campetella
Journal:  Glycobiology       Date:  2010-03-30       Impact factor: 4.313

Review 5.  The Trypanosoma cruzi Surface, a Nanoscale Patchwork Quilt.

Authors:  Juan Mucci; Andrés B Lantos; Carlos A Buscaglia; María Susana Leguizamón; Oscar Campetella
Journal:  Trends Parasitol       Date:  2016-11-11

6.  trans-Sialidase neutralizing antibody detection in Trypanosoma cruzi-infected domestic reservoirs.

Authors:  Paula A Sartor; Martha V Cardinal; Marcela M Orozco; Ricardo E Gürtler; M Susana Leguizamón
Journal:  Clin Vaccine Immunol       Date:  2011-04-06

7.  Circulating trans-sialidase activity and trans-sialidase-inhibiting antibodies in Trypanosoma cruzi-infected mice.

Authors:  N M Alcântara-Neves; L C Pontes-de-Carvalho
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

8.  Free fatty acids induce cell differentiation to infective forms in Trypanosoma cruzi.

Authors:  Marisa J Wainszelbaum; María L Belaunzarán; Estela M Lammel; Mónica Florin-Christensen; Jorge Florin-Christensen; Elvira L D Isola
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 9.  Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-Sialidase rides the show.

Authors:  Oscar Campetella; Carlos A Buscaglia; Juan Mucci; María Susana Leguizamón
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-01-20       Impact factor: 5.187

10.  Pneumococcal Haemophilus influenzae protein D conjugate vaccine induces antibodies that inhibit glycerophosphodiester phosphodiesterase activity of protein D.

Authors:  Maija Toropainen; Anna Raitolehto; Isabelle Henckaerts; Dominique Wauters; Jan Poolman; Pascal Lestrate; Helena Käyhty
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.